Inventors:
Barbara K. FINCK - Mercer Island WA, US
Larry O'Neal - Columbia SC, US
John D. Pluenneke - Kansas City MO, US
Timothy Connor - Madison WI, US
Assignee:
IMMUNEX CORPORATION - Thousand Oaks CA
International Classification:
A61K 38/17, C07K 14/71
Abstract:
The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNFα by administering a TNFα antagonist, such as recombinant TNFR:Fc.